C
Complement 1
Empowering cancer patients with expert-led sessions on exercise, nutrition, and well-being to enhance recovery and long-term health
About Complement 1
Complement 1 focuses on improving health outcomes for cancer patients through expert-led, one-on-one live sessions that cover exercise, nutrition, and overall well-being. The company operates in the healthcare sector, specifically targeting cancer survivors who seek to enhance their recovery and long-term health beyond traditional treatments like surgery and chemotherapy. Complement 1's business model revolves around providing a clinically validated adjunct lifestyle modification program, which is trauma-informed and designed to reduce cancer recurrence and mortality by 30-35%. The program addresses the gap in lifestyle care for cancer patients, offering personalized and daily human connection to help patients stay on track. Complement 1 generates revenue by offering these specialized sessions, which are not intended to replace medical treatments but to complement them. The company serves a niche market of cancer survivors who are often left to navigate post-treatment life on their own, providing them with the tools and support needed to improve their quality of life. Keywords: cancer, health outcomes, exercise, nutrition, well-being, recovery, lifestyle modification, personalized care, cancer survivors, adjunct program.
Source: Dealroom company dataLatest news
Press, funding announcements and product moves mentioning Complement 1.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | May 2025 | $16M | $64M | Blume Ventures · Owl Ventures | ↗ |
Growth signals
Latest recorded traffic for Complement 1 is 640 monthly website visits, up 137% over the last three months. Complement 1's team grew 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Blume Ventures
Owl Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Complement 1 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Complement 1’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







